Having trouble accessing articles? Reset your cache.

Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 2/15 cls
Adolor (NASDAQ:ADLR) Cowen Leland Gershell Upgrade Market outperform (from neutral) -5% $3.75
Gershell upgraded the stock after FDA extended the PDUFA date for an NDA for Entereg alvimopan capsules for the management of postoperative ileus (POI) to May 10 from Feb. 10. He believes the agency is comfortable with the drug's safety profile in this setting, but needs time to review the revised risk management plan for the selective peripherally acting mu opioid receptor antagonist.
BioMarin

Read the full 895 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE